NASHVILLE, Tenn., Nov. 4, 2010 /PRNewswire/ -- HealthLeaders-InterStudy, a leading provider of managed care market intelligence, reports that while the Cape Coral, Fla. market will face a decline in pharmaceutical sales due to rising uninsurance and increased generic utilization, the development of the high-risk pool and medical homes will help offset that decline. According to the recent Cape Coral Market Overview, the uninsurance rate in the Cape Coral area is well above both the state and national rate.
The report finds that the newly established high-risk pool for the uninsured in Florida is expected to draw between 15,000 and 35,000 residents statewide who have multiple chronic conditions and will use an estimated $145.8 million in prescription drugs by 2013. Drug usage will be focused on treating diabetes, hypertension, chronic obstructive pulmonary disease and congestive heart failure. In addition, the report also finds that medical home initiatives, such as Blue Cross and Blue Shield of Florida's pilot program, could create opportunities for pharmaceutical sales as prescription drug adherence is emphasized for patients with chronic conditions. Meanwhile, increased Medicaid enrollment could help decrease the uninsured rate.
"The Cape Coral market is facing some daunting changes," says HealthLeaders-InterStudy Market Analyst Chris Clancy. "The effects of the joblessness and increased generic utilization continue to be a drag on pharmaceutical sales. However, some effects of healthcare reform, such as the establishment of the high-risk pool, and the development of medical homes will help counterbalance those declining sales."
In addition to providing detailed analysis of how the uninsurance rates affect the Cape Coral market, the Cape Coral Market Overview provides local-level insights about:
Why Pharmaceutical Sales Representatives Need Market OverviewsMarket Overviews provide a detailed analysis of local healthcare market drivers in 87 of the nation's most dynamic metro areas.
About HealthLeaders-InterStudyHealthLeaders-InterStudy, a Decision Resources, Inc. company, is the authoritative source for managed care data, analysis and news. For more information, please visit www.HL-ISY.com.
About Decision Resources, Inc.Decision Resources, Inc. is a cohesive portfolio of companies that offers best-in-class, high-value information and insights on important sectors of the healthcare industry. Clients rely on this analysis and data to make informed decisions. Please visit Decision Resources, Inc. at www.DecisionResourcesInc.com.
All company, brand or product names contained in this document may be trademarks or registered trademarks of their respective holders.For more information, contact:Erin O'Leary
Decision Resources, Inc.781-993-2641
Copyright©2010 PR Newswire.
All rights reserved